Literature DB >> 1638255

Hodgkin's disease--I: Identification and classification.

P Carde1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1638255      PMCID： PMC1882623          DOI： 10.1136/bmj.305.6845.99

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  35 in total

1.  Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease.

Authors:  M Henry-Amar; R Somers
Journal:  Semin Oncol       Date:  1990-12       Impact factor: 4.929

Review 2.  The cell of origin in Hodgkin's disease.

Authors:  V Diehl; C von Kalle; C Fonatsch; H Tesch; M Jüecker; M Schaadt
Journal:  Semin Oncol       Date:  1990-12       Impact factor: 4.929

3.  Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease. A Southwest Oncology Group study.

Authors:  C M Mansfield; C Fabian; S Jones; E J Van Slyck; P Grozea; F Morrison; T P Miller; C Seibert; K Ayyangar
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

Review 4.  An epidemiologist's view of the new molecular biology findings in Hodgkin's disease.

Authors:  N Mueller
Journal:  Ann Oncol       Date:  1991-02       Impact factor: 32.976

Review 5.  The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma.

Authors:  H Stein; H Herbst; I Anagnostopoulos; G Niedobitek; F Dallenbach; H C Kratzsch
Journal:  Ann Oncol       Date:  1991-02       Impact factor: 32.976

Review 6.  Hodgkin's disease.

Authors:  W J Urba; D L Longo
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

7.  The value of laparotomy and splenectomy in the staging of Hodgkin's disease.

Authors:  E Glatstein; J M Guernsey; S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1969-10       Impact factor: 6.860

8.  Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease.

Authors:  M Jücker; H Abts; W Li; R Schindler; H Merz; A Günther; C von Kalle; M Schaadt; T Diamantstein; A C Feller
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

9.  Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.

Authors:  A Gause; C Pohl; A Tschiersch; L Da Costa; W Jung; V Diehl; D Hasenclever; M Pfreundschuh
Journal:  Blood       Date:  1991-05-01       Impact factor: 22.113

10.  Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.

Authors:  M Henry-Amar; S Friedman; M Hayat; R Somers; J H Meerwaldt; P Carde; J M Burgers; J Thomas; M Monconduit; E M Noordijk
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.